European Patent Office

T 0780/89 (Immunostimulant) du 12.08.1991

Identifiant européen de la jurisprudence
ECLI:EP:BA:1991:T078089.19910812
Date de la décision
12 août 1991
Numéro de l'affaire
T 0780/89
En ligne le
6 novembre 1991
Requête en révision de
-
Numéro de la demande
85102045.3
Classe de la CIB
A61K 31/53
Langue de la procédure
Allemand
Distribution
Publiées au Journal officiel de l'OEB (A)
Téléchargement
-
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
-
Nom du demandeur
Bayer
Nom de l'opposant
-
Chambre
3.3.02
Sommaire

1. General immunostimulation or stimulation of the body's own defences by the use of particular compounds, in conjunction with specific prophylaxis against certain infections, is to be classed as therapeutic treatment and therefore as not susceptible of industrial application in accordance with Article 52(4) EPC (point 6 of the Reasons for the Decision).

2. If an increase in meat production is merely the consequence of improved health and a lower death rate because of therapeutic treatment with a specific substance, this secondary effect does not deprive the use invention of the character of a therapeutic treatment excluded from patentability in accordance with Article 52(4), first sentence, EPC (point 7 of the Reasons for the Decision).

Dispositions juridiques pertinentes
European Patent Convention Art 52(4) 1973
Mots-clés
Therapeutic treatment
Prophylaxis
Immunostimulation
Exergue
-
Affaires citées
-

ORDER

For these reasons it is decided that:

1. The contested decision is set aside.

2. The matter is referred back to the Examining Division with the request that it grant a patent in accordance with the auxiliary request and an amended description.